Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial

Baysal A., SAĞIROĞLU G., Dogukan M., Ozkaynak I.

JOURNAL OF PERIANESTHESIA NURSING, cilt.37, sa.3, ss.326-332, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.jopan.2021.09.009
  • Dergi Adı: JOURNAL OF PERIANESTHESIA NURSING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, CINAHL, EMBASE, MEDLINE, DIALNET
  • Sayfa Sayıları: ss.326-332
  • Anahtar Kelimeler: sugammadex, neostigmine, neuromuscular blockade, residual neuromuscular blockade, postoperative complications, RESIDUAL NEUROMUSCULAR BLOCKADE, ADVERSE RESPIRATORY EVENTS, PULMONARY COMPLICATIONS, BLOCKING-AGENTS, CARE-UNIT, MULTICENTER, RISK, CURARIZATION, ANESTHESIA, IMPACT
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Purpose: The use of sugammadex at a lower dose after a routine reversal dose of neostigmine may prevent residual neuromuscular blockade (rNMB). Our goal was to investigate the effects of the use of half-dose sugammadex for reversing rNMB after administration of neostigmine, and compare these effects to a routine full-dose of neostigmine.